Reid Robison

Reid Robison serves as the Principal Investigator at Numinus, overseeing psychedelic and neuropsychiatric clinical trials focused on mental health conditions. Other current roles include Chief Clinical Officer at the Psychedelic Institute, Medical Director at PierianDx, and Adjunct Faculty at both the University of Utah School of Medicine and the University of Utah. Robison is also a founding board member of the Center for Change Treatment Programs and has experience as a coordinating investigator with the Multidisciplinary Association for Psychedelic Studies. Educational credentials include a medical degree from the University of Utah and an MBA from the David Eccles School of Business, along with fellowships in Biomedical Informatics and Neurodevelopmental Genetics from the same institution.